top of page
Home: Welcome
AdobeStock_785907461.jpeg

EXCELLENCE - INGENUITY - VISION

Reducing therapeutic cost & complexity for a brighter future

Solar Biomanufacturing

We are developing a novel platform for both the biomanufacture and delivery of biologics.

BIOMANUFACTURING BIOLOGICS FOR A BRIGHTER FUTURE

Bondi’s manufacturing and delivery platform is based on bioengineered, food-grade cyanobacteria which offers a cost-effective, self-formulating, and rapidly-scalable solution for a range of therapeutic modalities.

Our platform has great potential in the manufacture and delivery of VLP-based vaccines, therapeutic proteins & peptides, nucleic-acid-based treatments, and monoclonal antibodies for a wide range of diseases.

We simplify manufacturing using whole-cell solutions to significantly reduce complexity and costs, while enabling distributed biomanufacturing and point-of-care production.

APPLICATIONS

RELIABLE - ADAPTABLE - SCALABLE

BIOMANUFACTURING BIOLOGICS FOR A BRIGHTER FUTURE

We are developing a novel platform for the manufacture and delivery of biologics for a range of therapeutic modalities.

TECHNOLOGY

BUILDING THE FUTURE

We use our light and CO2-powered system to rapidly, reliably and safely produce self-formulating biologics in large quantities, at significantly reduced cost & complexity compared to current approaches.

Our technology combines cutting edge bioengineering with the latest advanced applications in health. Our cyanobacteria strains offer fast, controllable growth and ease of genetic manipulation. We use this power to create a flexible, scalable, customisable solution to manufacture and deliver biologics.

bottom of page